Foley Hoag Represents Cryoocyte in $4M Series A Financing
November 21, 2017
Foley Hoag LLP recently represented Cryoocyte, a reproductive technology platform for high-precision fish farming, in its $4 million Series A financing led by Aqua-Spark and existing investor Vodia Ventures. The company will use the funds to scale-up operations.
Cryoocyte offers a reproductive solution based on its technology for low temperature preservation of fish eggs that allows breeders and farmers to suspend reproductive process, generating previously unavailable data and allowing for precise mating decisions. The company mainly focuses on aquaculture in Norway, and has also done work in Chile and the United States.
Foley Hoag attorneys Mark Haddad and Jonathan Romiti advised Cryoocyte in the transaction.
About Foley Hoag LLP
Foley Hoag provides innovative, strategic legal services to public, private and government clients across the globe. We have premier capabilities in the life sciences, healthcare, technology, energy, professional services and private funds fields, and in cross-border disputes. The diverse backgrounds, perspectives and experiences of our lawyers and staff contribute to the exceptional service we deliver to clients ranging from startups to multinational companies to sovereign states. For more information, visit www.foleyhoag.com or follow @FoleyHoag on Twitter.